INTERNATIONAL ASSOCIATION FOR THE STUDY OF LUNG CANCER (Singapore–4:45 p.m. SPT/3:45 a.m. EST January 30, 2021–Using a host immune classifier (HIC) test for patients with non-small cell lung cancer (NSCLC) may provide better predictors of treatment response and improve outcomes, according to research presented today at the International Association for the Study of Lung Cancer’s 2020 World...